Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma

Hideki Iwamoto, Yu Noda(Kurume University), Tomotake Shirono(Kurume University), Masahito Nakano(Kurume University), Hajime Aino, Masahiko Kajiwara, Hironori Koga(Kurume University), Takuji Torimura(Omuta hospital), Naoki Kamachi(Kurume University), Norito Matsukuma(Yokkaichi Social Insurance Hospital), Kazunori Noguchi(Omuta hospital), Takako Nomura(Kagawa University), Hiroaki Nagamatsu, Miwa Sakai(Kurume University), Kazuhiro Kasai, Teiji Kuzuya(Nagoya University), Takato Ueno(Kurume University), Shigeo Shimose(Kurume University), Atsushi Hiraoka(Ehime Prefectural Central Hospital), Masatoshi Tanaka(Fukushima Medical University), Yoichi Yano, Rie Sugimoto(National Hospital Organization Kyushu Cancer Center), Kazuomi Ueshima(Kindai University), Yohei Kooka(Iwate Medical University), Kunitaka Fukuizumi(National Kyushu Medical Center), Ryoko Kuromatsu(Kurume University), Takashi Niizeki(Kurume University), Hiroshi Kawano(Shizuoka Cancer Center), Hirotaka Arai(Maebashi Red Cross Hospital), Hiroyuki Suzuki(Kurume University), Taizo Yamaguchi, Akihiro Deguchi(Kagawa University), Atsushi Kawaguchi(Kyoto University), Akio Ishihara(Osaka National Hospital), Satoshi Itano(Kurume University Hospital), Kei Ogata(Kurume University), Shusuke Okamura(Kurume University), Satoru Matsugaki(Kurume University), T Yonezawa(Japanese Red Cross Hadano Hospital)
Cancers
February 5, 2021
Cited by 32


Related Papers